- Egyptian International Pharmaceutical Industries Company (EIPICO)
Sector: Pharmaceuticals
Chairman and Managing Director: Ahmed Kelani
Market Value: $130 million
Sales: $109 million
Profits: $17 million
Assets: $208 million
EIPICO was established in 1980. In 2023, its products accounted for
25% of Egyptian pharmaceutical exports, covering 78 countries
worldwide. In 2023, it recorded total sales of $109 million, a growth of
32% compared to 2022. EIPICO is planning to open its EIPICO 3
factory in Q2 2024, which will be the first factory in Egypt and the
Middle East to produce biosimilars and its preparations, at an investment
of $100 million.
Egypt’s Top 50 Listed Companies 2024
